Ambrx Biopharma, Inc. Quarterly Common Stock, Shares Authorized from Q4 2022 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Ambrx Biopharma, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2022 to Q3 2023.
  • Ambrx Biopharma, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2023 was 136M shares.
Common Stock, Shares Authorized, Quarterly (shares)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 136M Sep 30, 2023 10-Q 2023-11-13
Q4 2022 71.4M Dec 31, 2022 10-Q 2023-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.